CompanyDrug

ApolloBio’s HPV Therapeutic Vaccine VGX-3100 Gets NMPA Green Light for Clinical Trial

CompanyDrug

Jacobio Pharma’s Pan-KRAS Inhibitor JAB-23E73 Clears FDA Hurdle for Clinical Trials

CompanyDrug

Hybribio’s Chloroquine Phosphate Gel Cleared for Clinical Trial on High-Risk HPV Infections

CompanyDrug

Ocumension Therapeutics’ OT-502 Receives NMPA Acceptance for Post-Cataract Inflammation Treatment

CompanyDrug

Yantai Dongcheng Pharmaceutical’s 18F-LNC1007 Receives Clinical Clearance for Solid Tumor Diagnostics

CompanyDrug

Fosun Pharmaceutical’s PD-1 Inhibitor HanSiZhuang Recommended for Approval by EMA’s CHMP

CompanyDeals

Tencent’s We Doctor Partners with CHA on National Digital Health Platform and Academic Initiatives

CompanyDeals

Huadong Medicine Secures Exclusive Rights to Janagliflozin for Type 2 Diabetes Treatment in China

Policy / Regulatory

Beijing Aims to Establish Rare Disease Drug Security Pilot Zone with ‘White List’ System

Policy / Regulatory

Beijing Authorities Release Negative List for Data Export in Key Industries

CompanyDrug

AstraZeneca’s HIMALAYA Trial Data Showcases Significant Survival Benefits for Liver Cancer Treatment at ESMO 2024

CompanyDrug

Aligos Therapeutics’ ALG-055009 Achieves Positive Topline Results in Phase 2a HERALD Study for MASH